American Society of Clinical Oncology
@ascocancer.bsky.social
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology.
The world’s leading professional organization representing more than 50,000 oncology professionals caring for people with cancer.
The world’s leading professional organization representing more than 50,000 oncology professionals caring for people with cancer.
Pinned
With three more ASCO meetings this year, there are still plenty of opportunities to connect with peers, discover groundbreaking cancer research, & gain clinical insights. Don't miss out on our meetings—the ultimate Place to Be.
Where will we see you this year?
Where will we see you this year?
Transformative discussions & world-class science are waiting at #GU27—The Place to Be Inspired! Connect w/ global leaders in San Francisco to translate paradigm-shifting discoveries into real-world pt outcomes.
Save on registration & hotels by Dec 16: https://bit.ly/3VIeeLl
@astro-org.bsky.social
Save on registration & hotels by Dec 16: https://bit.ly/3VIeeLl
@astro-org.bsky.social
September 23, 2026 at 2:00 PM
Transformative discussions & world-class science are waiting at #GU27—The Place to Be Inspired! Connect w/ global leaders in San Francisco to translate paradigm-shifting discoveries into real-world pt outcomes.
Save on registration & hotels by Dec 16: https://bit.ly/3VIeeLl
@astro-org.bsky.social
Save on registration & hotels by Dec 16: https://bit.ly/3VIeeLl
@astro-org.bsky.social
Our draft guideline protocol for “Management of Cancer-Related Sleep Disturbances: SIO-ASCO Guideline Protocol” is now open for public comment. Help us determine the scope of the guideline. Submit your comments to us by October 6.
Read and comment: https://bit.ly/4yLNfgd
Read and comment: https://bit.ly/4yLNfgd
September 22, 2026 at 8:15 PM
Our draft guideline protocol for “Management of Cancer-Related Sleep Disturbances: SIO-ASCO Guideline Protocol” is now open for public comment. Help us determine the scope of the guideline. Submit your comments to us by October 6.
Read and comment: https://bit.ly/4yLNfgd
Read and comment: https://bit.ly/4yLNfgd
ADCs have demonstrated impressive clinical activity across multiple gynecologic malignancies, but they have both risks & benefits as maintenance therapy. Read more from Dr. Premal Thaker & Dr. Joshua Brill of @washumedicine.bsky.social for #ASCODailyNews: https://bit.ly/4dICvHh
September 21, 2026 at 2:00 PM
ADCs have demonstrated impressive clinical activity across multiple gynecologic malignancies, but they have both risks & benefits as maintenance therapy. Read more from Dr. Premal Thaker & Dr. Joshua Brill of @washumedicine.bsky.social for #ASCODailyNews: https://bit.ly/4dICvHh
Just a few days left to apply for the @conquercancer.bsky.social IDEA program! If you are an early-career oncologist in an LMIC looking for mentorship and a chance to attend #ASCO27, don't let this deadline pass. Applications are due September 30, 2026.
Apply here: https://bit.ly/4rjRP2P
Apply here: https://bit.ly/4rjRP2P
September 18, 2026 at 2:00 PM
Just a few days left to apply for the @conquercancer.bsky.social IDEA program! If you are an early-career oncologist in an LMIC looking for mentorship and a chance to attend #ASCO27, don't let this deadline pass. Applications are due September 30, 2026.
Apply here: https://bit.ly/4rjRP2P
Apply here: https://bit.ly/4rjRP2P
High-impact GI cancer care starts w/ groundbreaking research. If you want to gain valuable global insights & fuel your career, submit an abstract to #GI27.
We are accepting submissions for both oral & poster presentations, so submit your abstract by Sept. 22: https://bit.ly/3SOyjyO
We are accepting submissions for both oral & poster presentations, so submit your abstract by Sept. 22: https://bit.ly/3SOyjyO
September 17, 2026 at 2:00 PM
High-impact GI cancer care starts w/ groundbreaking research. If you want to gain valuable global insights & fuel your career, submit an abstract to #GI27.
We are accepting submissions for both oral & poster presentations, so submit your abstract by Sept. 22: https://bit.ly/3SOyjyO
We are accepting submissions for both oral & poster presentations, so submit your abstract by Sept. 22: https://bit.ly/3SOyjyO
🎙 #EdBook EIC Dr. Gerald Hsu of @ucsfcancer.bsky.social & Dr. Christopher Booth of Queen's University discuss actionable strategies for clinicians to re-center cancer care on shared decision-making, transparent risk communication, & patient-centered care on #ByTheBook Podcast: https://bit.ly/3Vuahd5
September 16, 2026 at 5:00 PM
🎙 #EdBook EIC Dr. Gerald Hsu of @ucsfcancer.bsky.social & Dr. Christopher Booth of Queen's University discuss actionable strategies for clinicians to re-center cancer care on shared decision-making, transparent risk communication, & patient-centered care on #ByTheBook Podcast: https://bit.ly/3Vuahd5
The ASCO Association PAC is a great way to unify cancer community voices, esp. in an election year. We can reach policymakers directly & support those that keep cancer care & research a priority. Learn more on Sept. 23 at the PAC 101 webinar: https://bit.ly/4xySVJK #ASCOAdvocacy
September 16, 2026 at 2:00 PM
The ASCO Association PAC is a great way to unify cancer community voices, esp. in an election year. We can reach policymakers directly & support those that keep cancer care & research a priority. Learn more on Sept. 23 at the PAC 101 webinar: https://bit.ly/4xySVJK #ASCOAdvocacy
Updated ASCO Guideline: Systemic Therapy in Patients w/ Metastatic Castration-Resistant Prostate Cancer. Including evidence from prev. trials along w/ 2 additional trials & updates algorithms for biomarker-informed treatment selection.
Read the guideline: https://bit.ly/3UTCkT5
Read the guideline: https://bit.ly/3UTCkT5
September 14, 2026 at 8:15 PM
Updated ASCO Guideline: Systemic Therapy in Patients w/ Metastatic Castration-Resistant Prostate Cancer. Including evidence from prev. trials along w/ 2 additional trials & updates algorithms for biomarker-informed treatment selection.
Read the guideline: https://bit.ly/3UTCkT5
Read the guideline: https://bit.ly/3UTCkT5
Upcoming Medicaid work requirements starting in 2027 could impact coverage and care delivery for patients with cancer. We break down what these policy changes mean and how we are working to protect patient access to care. Learn more: https://bit.ly/4rcyCA4
#ASCOAdvocacy
#ASCOAdvocacy
September 14, 2026 at 2:00 PM
Upcoming Medicaid work requirements starting in 2027 could impact coverage and care delivery for patients with cancer. We break down what these policy changes mean and how we are working to protect patient access to care. Learn more: https://bit.ly/4rcyCA4
#ASCOAdvocacy
#ASCOAdvocacy
Last call for established profs: Letters of Intent for the Research Professorship in Ovarian Cancer are due 9/23. Secure flexible funding to support your overall research activities & train the next generation of leaders. Supported by @conquercancer.bsky.social. Submit ⏩https://bit.ly/4iifmPj
September 11, 2026 at 2:00 PM
Last call for established profs: Letters of Intent for the Research Professorship in Ovarian Cancer are due 9/23. Secure flexible funding to support your overall research activities & train the next generation of leaders. Supported by @conquercancer.bsky.social. Submit ⏩https://bit.ly/4iifmPj
Dr. Sumanta Pal of @cityofhope.bsky.social and pioneering investigator Dr. Jedd Wolchok of Weill Cornell Medicine discuss the remarkable evolution in melanoma treatments on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/3SzPqnW
September 10, 2026 at 5:00 PM
Dr. Sumanta Pal of @cityofhope.bsky.social and pioneering investigator Dr. Jedd Wolchok of Weill Cornell Medicine discuss the remarkable evolution in melanoma treatments on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/3SzPqnW
We join the oncology community in mourning the passing of Dr. Robert A. Kyle, whose transformative hematology research was celebrated with our Karnofsky Award in 2007.
Learn more about Dr. Kyle's career: https://bit.ly/4h2E4AR
Learn more about Dr. Kyle's career: https://bit.ly/4h2E4AR
September 9, 2026 at 8:00 PM
We join the oncology community in mourning the passing of Dr. Robert A. Kyle, whose transformative hematology research was celebrated with our Karnofsky Award in 2007.
Learn more about Dr. Kyle's career: https://bit.ly/4h2E4AR
Learn more about Dr. Kyle's career: https://bit.ly/4h2E4AR
Immerse yourself in cutting-edge science and learn the solution-focused strategies that can elevate your patient outcomes at #GI27.
Registration is now open, so secure your spot today to save: https://bit.ly/4cmBW5v
Registration is now open, so secure your spot today to save: https://bit.ly/4cmBW5v
September 8, 2026 at 2:00 PM
Immerse yourself in cutting-edge science and learn the solution-focused strategies that can elevate your patient outcomes at #GI27.
Registration is now open, so secure your spot today to save: https://bit.ly/4cmBW5v
Registration is now open, so secure your spot today to save: https://bit.ly/4cmBW5v
If our LDP is on your vision board this year, the clock is ticking! This is more than just a line on your CV: it’s your fast track to a global network of mentors, career-defining skills, and peers that’ll help you advance your career.
Ready to make your move? Apply by 9/14: https://bit.ly/4qZHV6j
Ready to make your move? Apply by 9/14: https://bit.ly/4qZHV6j
September 7, 2026 at 5:00 PM
If our LDP is on your vision board this year, the clock is ticking! This is more than just a line on your CV: it’s your fast track to a global network of mentors, career-defining skills, and peers that’ll help you advance your career.
Ready to make your move? Apply by 9/14: https://bit.ly/4qZHV6j
Ready to make your move? Apply by 9/14: https://bit.ly/4qZHV6j
It's never too early to make your voting plan! The U.S. General Election is quickly approaching. Visit nass.org/can-I-vote to check your registration status, learn your state’s rules on mail-in voting, and much more! #ASCOAdvocacy
September 7, 2026 at 2:00 PM
It's never too early to make your voting plan! The U.S. General Election is quickly approaching. Visit nass.org/can-I-vote to check your registration status, learn your state’s rules on mail-in voting, and much more! #ASCOAdvocacy
🎙 Dr. Monty Pal of @cityofhope.bsky.social and Dr. Petros Grivas discuss major updates in treating bladder cancer, including managing toxicities in clinical practice, on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/4h6XIgi
September 4, 2026 at 5:00 PM
🎙 Dr. Monty Pal of @cityofhope.bsky.social and Dr. Petros Grivas discuss major updates in treating bladder cancer, including managing toxicities in clinical practice, on the latest episode of the #ASCODailyNews Podcast: https://bit.ly/4h6XIgi
Last month, we collaborated with City Cancer Challenge (C/Can) for a Multidisciplinary Cancer Management Course (MCMC) in Concepción, Chile.
Thank you to the dedicated attendees, expert faculty, and our partners at City Cancer Challenge for an incredible week of shared learning!
#ASCOGlobalImpact
Thank you to the dedicated attendees, expert faculty, and our partners at City Cancer Challenge for an incredible week of shared learning!
#ASCOGlobalImpact
September 4, 2026 at 2:00 PM
Last month, we collaborated with City Cancer Challenge (C/Can) for a Multidisciplinary Cancer Management Course (MCMC) in Concepción, Chile.
Thank you to the dedicated attendees, expert faculty, and our partners at City Cancer Challenge for an incredible week of shared learning!
#ASCOGlobalImpact
Thank you to the dedicated attendees, expert faculty, and our partners at City Cancer Challenge for an incredible week of shared learning!
#ASCOGlobalImpact
Thank you ASCO member Dr. @fumikochino.bsky.social for speaking on the importance of federal cancer research funding! #ASCOAdvocacy continues to urge Congress to pass a full, bipartisan FY27 bill to provide the strongest possible investments in medical research.
The Battle for Cancer Research Funding: What You Need to Know
YouTube video by Money Matters Podcast | HFFG
www.youtube.com
September 3, 2026 at 5:00 PM
Thank you ASCO member Dr. @fumikochino.bsky.social for speaking on the importance of federal cancer research funding! #ASCOAdvocacy continues to urge Congress to pass a full, bipartisan FY27 bill to provide the strongest possible investments in medical research.
Reposted by American Society of Clinical Oncology
ASCO is pleased to name Thomas E. Stinchcombe, MD, FASCO from @dukecancer.bsky.social as the new Editor-in-Chief of JCO, beginning January 2027.
Dr. Stinchcombe’s expertise will drive innovation, faster publication timelines, and expanded global reach for high-impact cancer research.
Dr. Stinchcombe’s expertise will drive innovation, faster publication timelines, and expanded global reach for high-impact cancer research.
September 2, 2026 at 1:00 PM
ASCO is pleased to name Thomas E. Stinchcombe, MD, FASCO from @dukecancer.bsky.social as the new Editor-in-Chief of JCO, beginning January 2027.
Dr. Stinchcombe’s expertise will drive innovation, faster publication timelines, and expanded global reach for high-impact cancer research.
Dr. Stinchcombe’s expertise will drive innovation, faster publication timelines, and expanded global reach for high-impact cancer research.
Last call! Early-career oncologists: secure research funding and advance your career.
📢 Apply for a mentored @conquercancer.bsky.social YIA or GO YIA by Sept. 10.
Don't miss out—submit today: https://bit.ly/4iHfuYz
#GrantOpportunity #ResearchConquersCancer
📢 Apply for a mentored @conquercancer.bsky.social YIA or GO YIA by Sept. 10.
Don't miss out—submit today: https://bit.ly/4iHfuYz
#GrantOpportunity #ResearchConquersCancer
September 3, 2026 at 2:00 PM
Last call! Early-career oncologists: secure research funding and advance your career.
📢 Apply for a mentored @conquercancer.bsky.social YIA or GO YIA by Sept. 10.
Don't miss out—submit today: https://bit.ly/4iHfuYz
#GrantOpportunity #ResearchConquersCancer
📢 Apply for a mentored @conquercancer.bsky.social YIA or GO YIA by Sept. 10.
Don't miss out—submit today: https://bit.ly/4iHfuYz
#GrantOpportunity #ResearchConquersCancer
⌚ Time is running out to level up your #MedEd game! We’re looking for the next wave of ed innovators to join the 2027-28 LDP: Education Scholars program.
If you’re ready to master learning science & lead the charge, apply by Sept. 14: https://bit.ly/46xjYKa
If you’re ready to master learning science & lead the charge, apply by Sept. 14: https://bit.ly/46xjYKa
September 2, 2026 at 2:00 PM
⌚ Time is running out to level up your #MedEd game! We’re looking for the next wave of ed innovators to join the 2027-28 LDP: Education Scholars program.
If you’re ready to master learning science & lead the charge, apply by Sept. 14: https://bit.ly/46xjYKa
If you’re ready to master learning science & lead the charge, apply by Sept. 14: https://bit.ly/46xjYKa
What’s the optimal follow-up visit schedule for patients with #breastcancer? The latest ASCO guideline update recommends a risk-based approach. See the highlights in #ASCODailyNews: https://bit.ly/4xwJoUh
September 1, 2026 at 5:00 PM
What’s the optimal follow-up visit schedule for patients with #breastcancer? The latest ASCO guideline update recommends a risk-based approach. See the highlights in #ASCODailyNews: https://bit.ly/4xwJoUh
RFPs are open for the 2027-2029 ASCO International Palliative Care Education Collaboration! Health orgs in LMICs working in cancer: collaborate on a multi-year project featuring a Train the Trainer program, intro virtual courses, & advanced in-person courses.
Apply by 11/30: https://bit.ly/4zQjOef
Apply by 11/30: https://bit.ly/4zQjOef
September 1, 2026 at 2:00 PM
RFPs are open for the 2027-2029 ASCO International Palliative Care Education Collaboration! Health orgs in LMICs working in cancer: collaborate on a multi-year project featuring a Train the Trainer program, intro virtual courses, & advanced in-person courses.
Apply by 11/30: https://bit.ly/4zQjOef
Apply by 11/30: https://bit.ly/4zQjOef
Reaching a target long thought "undruggable,” a newly approved RAS inhibitor nearly doubled survival in metastatic pancreatic cancer. What once seemed impossible is giving new hope to countless families.
Tell Congress to protect critical research funding: https://bit.ly/4gxncSo #ASCOAdvocacy
Tell Congress to protect critical research funding: https://bit.ly/4gxncSo #ASCOAdvocacy
August 31, 2026 at 2:20 PM
Reaching a target long thought "undruggable,” a newly approved RAS inhibitor nearly doubled survival in metastatic pancreatic cancer. What once seemed impossible is giving new hope to countless families.
Tell Congress to protect critical research funding: https://bit.ly/4gxncSo #ASCOAdvocacy
Tell Congress to protect critical research funding: https://bit.ly/4gxncSo #ASCOAdvocacy
Earlier this week, we issued our first Living Guideline on systemic treatment of recurrent ovarian cancer. For more on what this Living Guideline addresses, including interviews with the Expert Panel co-chairs, read this concise analysis from #ASCODailyNews: https://bit.ly/4d56vgd
August 28, 2026 at 8:00 PM
Earlier this week, we issued our first Living Guideline on systemic treatment of recurrent ovarian cancer. For more on what this Living Guideline addresses, including interviews with the Expert Panel co-chairs, read this concise analysis from #ASCODailyNews: https://bit.ly/4d56vgd